Sanofi to launch Enzymatica’s product in Turkey
Premium
5 April 2022
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, in Turkey.
Industry News - Tag: Sanofi Consumer Healthcare
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Sanofi to launch Enzymatica’s product in Turkey
Sanofi changes model in Chile, Paraguay and Uruguay
Premium
4 April 2022
Sanofi Consumer Healthcare will be commercialising its products in Chile, Paraguay and Uruguay through partners from 1 June 2022.
Sanofi and Enzymatica add Mexico to partnership
Premium
14 March 2022
Sanofi Consumer Healthcare has extended its licensing deal for Enzymatica’s mouth spray against the common to include Mexico as well as France and Italy.
Sanofi Consumer Healthcare up 5.6% as complexity cut
Premium
7 February 2022
Sanofi Consumer Healthcare said it had reduced its trademarks by 50% and its domain names by 30% as it reported worldwide sales up by 5.6% at constant exchange rates in the fourth quarter of 2021.
Sanofi exits 111 brands as sales rise by 11.1%
Premium
11 November 2021
Sanofi Consumer Healthcare said it had discontinued production or announced divestments for 111 brands as it reported worldwide sales up by 11.1% in the third quarter of 2021.
Sanofi Consumer Healthcare returns to growth
Premium
3 August 2021
Sanofi Consumer Healthcare returned to growth in the second quarter of 2021 following four quarters of declining sales.
Sanofi India to divest nutraceuticals business
Premium
30 July 2021
Sanofi India is divesting its nutraceuticals business – including the Seacod and E-Cod cod liver oil brands – to Universal Nutriscience in a deal worth INR5.87 billion (USD0.08 billion) including debt.
Sanofi and Stada strike major distribution deal
Premium
28 July 2021
Sanofi is handing over distribution and marketing of around 50 consumer healthcare brands in 20 European countries to Germany’s Stada.
Hypera to acquire portfolio of brands from Sanofi
Premium
14 July 2021
Brazil’s Hypera Pharma is acquiring a portfolio of OTC and prescription brands – including the analgesic AAS and the herbal medicine Naturetti – from Sanofi for USD190 million.
Stada snaps up portfolio of brands from Sanofi
Premium
29 June 2021
Stada is strengthening its European consumer healthcare presence by acquiring 16 local and regional brands – including Silomat, Mitosyl and Frubiase – from Sanofi Consumer Healthcare for an undisclosed sum.